0,900$
-2,17%
Echtzeit-Aktienkurs Predictive Oncology
Bid:
Ask:
Echtzeit-Chart der Predictive Oncology Aktie
Börsenkurse Predictive Oncology
Fundamentaldaten der Predictive Oncology Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2022 [USD] | 1,51 Mio. | -25,74 Mio. | -25,74 Mio. | -0,35 | - | - | 47,47 |
| 2021 [USD] | 1,42 Mio. | -20,32 Mio. | -19,66 Mio. | -0,36 | - | - | 41,57 |
| 2020 [USD] | 1,25 Mio. | -25,88 Mio. | -25,88 Mio. | -2,21 | - | - | 14,23 |
| 2019 [USD] | 1,41 Mio. | -19,39 Mio. | -19,39 Mio. | -6,86 | - | - | 2,59 |
| 2018 [USD] | 1,41 Mio. | -10,09 Mio. | -10,09 Mio. | -7,87 | - | - | 0,90 |
| 2017 [USD] | 0,65 Mio. | -7,75 Mio. | -7,75 Mio. | -12,20 | - | - | 0,95 |
| 2016 [USD] | 0,46 Mio. | -6,53 Mio. | -6,53 Mio. | -23,10 | - | - | 0,90 |
| 2015 [USD] | 0,65 Mio. | -4,79 Mio. | -4,79 Mio. | -307,50 | - | - | 0,03 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Predictive Oncology Aktie
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment is composed of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in prote